What You Should Know:
- A new study published in the Journal of Medical Artificial Intelligence explores the potential of large language models (LLMs), like GPT-4, to act as valuable tools for clinicians.
- Study author Marc D. Succi, MD, strategic innovation leader at Mass General Brigham Innovation, and his team investigated the use of GPT-4 in recommending physical exam instructions based on patient symptoms. For example, if a patient presented with a painful hip, GPT-4 would
Read More
ŌURA Secures $200M to Fuel Growth and Innovation in Health Wearables
What You Should Know:
- ŌURA, the company behind the world's leading smart ring, has announced the completion of a $200 million Series D funding round, raising its valuation to $5.2B.
- This significant investment, with participation from Fidelity Management & Research Company and Dexcom, reflects ŌURA's strong momentum and its potential to transform the healthcare landscape.
Driving the Future of Health Wearables
ŌURA has been redefining health wearables since its
Read More
Remodel Health Raises Over $100M to Expand ICHRAs
What You Should Know:
- Remodel Health, a provider of Individual Coverage Health Reimbursement Arrangements (ICHRAs), has announced a significant growth funding round of over $100M. ICHRAs offer employers predictable annual benefits costs, providing stability and potential cost savings compared to traditional group health insurance.
- The investment, led by Oak HC/FT and Hercules Capital, will support Remodel Health's continued expansion and innovation in the ICHRA
Read More
Personalis Secures $50M from Merck, Extends Collaboration with Moderna
What You Should Know:
- Personalis, Inc. (NASDAQ: PSNL) today announced agreements with long-time collaborators Merck and Moderna that accelerate the advancement of the company’s business strategy.
- The company has received a $50M investment from Merck, known as MSD outside the United States and Canada, and separately has signed a multi-year extension with Moderna to utilize Personalis’ ImmunoID NeXT Platform® and technology for V940/mRNA-4157, an investigational
Read More
Aspirion Acquires Boost Healthcare to Enhance RCM Capabilities
What You Should Know:
- Aspirion, a provider of healthcare technology revenue cycle management (RCM) solutions, today announced the acquisition of Boost Healthcare, a revenue cycle firm that joins revenue cycle leaders on their journey to improve their organization’s financial performance. Financial details of the acquisition were not disclosed.
- The strategic acquisition strengthens Aspirion's commitment to helping healthcare providers secure accurate and timely reimbursement for
Read More
symplr Appoints Steve Filler as COO and Matt Grill as CDO to Drive Operational Excellence
What You Should Know:
- symplr, a provider of enterprise healthcare operations software, has announced the appointment of Steve Filler as Chief Operating Officer (COO) and Matt Grill as Chief Delivery Officer (CDO).
- These strategic appointments bring extensive leadership experience and expertise to symplr, further strengthening the company's commitment to delivering innovative solutions and exceptional customer service.
Steve Filler: Driving Strategic Vision and
Read More
Amwell CFO Mark Hirschhorn Expands Leadership Role to COO
What You Should Know:
- Amwell, a provider of digital healthcare solutions, has announced that its Chief Financial Officer (CFO), Mark Hirschhorn, will assume an expanded role as Chief Operating Officer (COO), effective January 1, 2025.
- The alignment reflects Amwell's focus on streamlining operations and scaling its business to meet the increasing demand for digital healthcare services.
Expanded Responsibilities for CFO
In his new role, Hirschhorn will oversee Amwell's
Read More
Scripta Insights Raises $17M for AI-Powered Pharmacy Navigation
What You Should Know:
- Scripta Insights, an AI-powered pharmacy navigation platform, has secured $17M in Series B funding led by Aquiline, a private investment firm specializing in financial services and technology.
- The latest investment brings Scripta's total funding to $42M and supports its mission to address the rising cost of prescription drugs in the United States.
Addressing the Prescription Drug Affordability Crisis
The cost of prescription drugs is a significant
Read More
Benchstrength Closes $62M Early-Stage VC Fund with Healthcare Focus
What You Should Know:
- Benchstrength, a New York City-based venture capital firm, has announced the close of its first $62M fund, focused on investing in high-potential, early-stage technology companies.
- The $62M fund has attracted a diverse group of investors, including prominent foundations, institutional investors, and individual investors.
Investing in Transformative Technologies
Led by former General Catalyst investors Ken Chenault Jr. and John Monagle,
Read More
BrightInsight, Sanofi to Build Drug Companion Apps for its Major Specialty Therapies
What You Should Know:
- BrightInsight, Inc., a provider of regulated digital health solutions, has announced an expanded multi-year partnership with Sanofi, a global biopharmaceutical company. This expanded partnership builds on a successful collaboration that began in 2022 when Sanofi selected the BrightInsight Platform to accelerate the development of a SaMD for one of its specialty care medicines.
- The goal of the collaboration aims to accelerate Sanofi's drug development timeline and
Read More
